Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeuroPace Q2 2024 GAAP EPS $(0.26) Beats $(0.31) Estimate, Sales $19.256M Beat $18.297M Estimate

Author: Benzinga Newsdesk | August 13, 2024 04:19pm
NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. The company reported quarterly sales of $19.256 million which beat the analyst consensus estimate of $18.297 million by 5.24 percent. This is a 16.63 percent increase over sales of $16.510 million the same period last year.

Posted In: NPCE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist